Navigation Links
Radiation Oncology Institute Campaign Raises $3 Million
Date:9/10/2008

Varian Medical Systems pledges $2 million toward $10 million campaign goal

FAIRFAX, Va., Sept. 10 /PRNewswire-USNewswire/ -- The newly formed Radiation Oncology Institute has so far raised $3 million as part of its initial campaign goal and is on target to achieve its $10 million initial campaign goal.

Following an initial commitment of $5 million from the American Society for Therapeutic Radiology and Oncology -- $3 million of which is a challenge grant to ASTRO members, individual radiation oncologists have done their part by pledging nearly $1 million in commitments to date. With the critical mass pledged by the physicians and radiation therapy treatment team members, industry partners were invited to join the campaign as well. Radiation therapy equipment manufacturer Varian did so with a leadership commitment of $2 million.

"We all know that radiation therapy is one of the most powerful weapons available to patients fighting cancer, particularly in light of advances made in the last 10 years. Radiation therapy is not only clinically effective, it is cost effective, too," said Timothy E. Guertin, CEO of Varian Medical Systems in Palo Alto, Calif. "The problem is that the rest of the world doesn't seem to get it. Many patients, members of the public, referring physicians, surgical and medical oncologists, and policy makers continue to think of radiation as a therapy of last resort, rather than a therapy to be preferred. We are excited to be a part of ROI since its goals are to improve the position and standing of radiation oncology and demonstrate the value and clinical benefits that this important treatment brings to improve and extend the lives of cancer patients every day."

"Our plan is for ROI to conduct objective research on the specialty to document the value, safety, efficacy and cost effectiveness of radiation therapy with the goal of 'stepping up' the profile of radiation therapy within the medical community to ensure that cancer patients have access to the treatments that are best for them, their lifestyle and their cancer," said Campaign Co-chair Colleen A. Lawton, M.D., FASTRO, from the Medical College of Wisconsin in Milwaukee. "It is gratifying to see so many of my physician colleagues as well as Varian step up to support this exciting initiative."

"I am excited that so many of my colleagues believe in the vision of ROI to develop open, objective research that will demonstrate the value that radiation oncology brings to cancer care throughout the world," said Campaign Co-chair Theodore S. Lawrence, M.D., Ph.D., FASTRO, from the University of Michigan in Ann Arbor, Mich.

For more information on ROI, including a list of donors and information on contributing, please visit http://www.roinstitute.org.

The Radiation Oncology Institute was established to develop innovative ways of enhancing the profile of radiation oncology in the world cancer community and prepare the specialty for the future. For more information, visit http://www.roinstitute.org.


'/>"/>
SOURCE American Society for Therapeutic Radiology
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Informational handout key to giving parents a better understanding of CT radiation risks
2. Prophylactic cranial irradiation in small cell lung cancer significantly increases survival
3. Different method of evaluating the urinary tract system reduces radiation dose
4. Radiation and drug combo helps boost efficacy of lung cancer treatment
5. Nucletron Announces Management Buy-Out to More Effectively Meet the Demands of Its Customers and the Radiation Therapy Community
6. Radiation therapy technique reduces length of prostate cancer treatment
7. Radiation therapy technique reduces length of prostate cancer treatment
8. Jefferson radiation oncologists use real-time system to plant seeds against cancer
9. Radiation Therapy Services Acquires North Carolina Facility
10. NASA, NSBRI Select 17 Proposals in Space Radiation Research
11. Breast Cancer Radiation Wont Hurt Immune Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... Those ... deal with these feelings, many turn to unhealthy avenues, such as drug or alcohol ... of Marne, Michigan, has released tools for healthy coping following a traumatic event. , ...
(Date:6/24/2016)... ... ... in a crisis. Her son James, eight, was out of control. Prone to extreme mood ... something upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a ... children and say he was going to kill them. If we were driving on ...
(Date:6/24/2016)... ... 24, 2016 , ... Global law firm Greenberg Traurig, P.A. announced that 20 ... by their peers for this recognition are considered among the top 2 percent of ... honors as members of this year’s Legal Elite Hall of Fame: Miami Shareholders ...
(Date:6/24/2016)... ... , ... Comfort Keepers® of San Diego, CA is excited to announce they ... to drive cancer patients to and from their cancer treatments. Comfort Keepers provides ... life and ongoing independence. Getting to and from medical treatments is one of ...
(Date:6/24/2016)... , ... June 24, 2016 , ... People across the ... Genome magazine’s Code Talker Award, an essay contest in which patients and their families ... to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual Education ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
Breaking Medicine Technology: